Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Originalsprog | Engelsk |
---|---|
Tidsskrift | Diabetologia |
Vol/bind | 67 |
Udgave nummer | 1 |
Sider (fra-til) | 3-18 |
Antal sider | 16 |
ISSN | 0012-186X |
DOI | |
Status | Udgivet - 2024 |
Bibliografisk note
Funding Information:
VSS is supported by a Department of Medicine Eliot Phillipson Clinician-Scientist Training Program, a Banting and Best Diabetes Centre Postdoctoral Fellowship at the University of Toronto and a Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Research Award. CPL is supported by an American Kidney Fund’s Clinical Scientist in Nephrology Award. DZIC is supported by a Department of Medicine, University of Toronto Merit Award and receives support from the CIHR, Diabetes Canada and the Heart & Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research. DZIC is also the recipient of a 5 year CIHR–Kidney Foundation of Canada Team Grant Award. PR is supported by a Novo Nordisk Foundation grant (NNF22OC0077730; ‘Multifactorial intervention to reduce cardiorenal disease in type 1 diabetes – a prospective, randomised, open, multicenter study – the Steno 1 study’). JSS is supported by the Diabetes Research Institute Foundation.
Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
ID: 377994120